Results 191 to 200 of about 22,103 (214)
Some of the next articles are maybe not open access.

Chaperone‐rich cell lysate embedded with BCR‐ABL peptide demonstrates enhanced anti‐tumor activity against a murine BCR‐ABL positive leukemia

The FASEB Journal, 2007
Chaperone proteins are effective antitumor vaccines when purified from a tumor source, some of which are in clinical trials. Such vaccines culminate in tumor-specific T cell responses, implicating the role of adaptive immunity. We have developed a rapid and efficient procedure utilizing an isoelectric focusing technique to obtain vaccines from tumor or
Gang Li   +4 more
openaire   +2 more sources

Advances in BCR/ABL positive ALL

ADVANCES IN CELL AND GENE THERAPY, 2019
Jacob M. Rowe   +4 more
openaire   +2 more sources

Bcl2 as a therapeutic target in BCR-ABL positive ALL

Klinische Pädiatrie, 2014
Alex Elder   +3 more
openaire   +2 more sources

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila K Nanayakkara   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan   +2 more
exaly  

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2020
Carmen E Guerra   +2 more
exaly  

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis   +2 more
exaly  

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2018
Timothy R Church   +2 more
exaly  

Home - About - Disclaimer - Privacy